Use of Antidepressants for Management of Hot Flashes
Authors:
- 1 November 2009
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 29 (11) , 1357-1374
Abstract
A growing body of evidence suggests that antidepressant therapies, particularly selective serotonin reuptake inhibitors and venlafaxine, are effective in the management of hot flash symptoms. Several of these agents have the support of the American College of Obstetricians and Gynecologists and the North American Menopause Society. To review the literature on antidepressants for the treatment of hot flashes in women, we searched the PubMed, International Pharmaceutical Abstracts, and MEDLINE databases from inception through May 2009. All publication types that included human participants and that were published in English were eligible for review. These articles, relevant abstracts, and additional references were used to collect pertinent data. Although initial small pilot trials were conducted solely in breast cancer survivors, additional studies have been conducted both in breast cancer survivors and in relatively healthy menopausal women. Data on the benefits with many of these agents are conflicting. Venlafaxine and paroxetine have been studied more extensively than any of the other antidepressants and are more consistent in effectively reducing the frequency and severity of hot flashes, based on these study results. Desvenlafaxine, sertraline, fluoxetine, and citalopram should be considered second‐ or third‐line options if patients fail therapy with or cannot tolerate venlafaxine or paroxetine, based on the current published data. Duloxetine, escitalopram, fluvoxamine, and mirtazapine should be reserved as last‐line therapy until more rigorous studies are conducted assessing their use in the management of hot flashes.Keywords
This publication has 44 references indexed in Scilit:
- Paroxetine Versus Placebo for Women in Midlife After Hormone Therapy DiscontinuationThe American Journal of Medicine, 2008
- Ineffectiveness of Sertraline for Treatment of Menopausal Hot FlushesObstetrics & Gynecology, 2007
- Phase III Trial of Gabapentin Alone or in Conjunction With an Antidepressant in the Management of Hot Flashes in Women Who Have Inadequate Control With an Antidepressant Alone: NCCTG N03C5Journal of Clinical Oncology, 2007
- Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Sertraline (Zoloft) for the Treatment of Hot Flashes in Women with Early Stage Breast Cancer Taking TamoxifenThe Breast Journal, 2006
- Paroxetine Is an Effective Treatment for Hot Flashes: Results From a Prospective Randomized Clinical TrialJournal of Clinical Oncology, 2005
- Pilot Evaluation of Citalopram for the Treatment of Hot Flashes in Women with Inadequate Benefit from VenlafaxineJournal of Palliative Medicine, 2005
- Short‐term combinational therapy of low‐dose estrogen with selective serotonin re‐uptake inhibitor (fluvoxamine) for oophorectomized women with hot flashes and depressive tendenciesJournal of Obstetrics and Gynaecology Research, 2005
- Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depressionDepression and Anxiety, 2005
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Venlafaxine for the Control of Hot Flashes: Results of a Longitudinal Continuation StudyOncology Nursing Forum, 2002